Found: 17
Select item for more details and to access through your institution.
Human anti-mouse antibody suppression with cyclosporin A.
- Published in:
- Cancer (0008543X), 1994, v. 73, n. S3, p. 1093, doi. 10.1002/1097-0142(19940201)73:3+<1093::AID-CNCR2820731349>3.0.CO;2-#
- By:
- Publication type:
- Article
MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 11, p. 1884, doi. 10.2967/jnumed.108.053173
- By:
- Publication type:
- Article
Dosimetry of solid tumors.
- Published in:
- Medical Physics, 1993, v. 20, n. 2, p. 583, doi. 10.1118/1.597053
- By:
- Publication type:
- Article
<sup>166</sup>Ho-DOTMP Radiation-Absorbed Dose Estimation for Skeletal Targeted Radiotherapy.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 3, p. 534
- By:
- Publication type:
- Article
Blood-Based Red Marrow Dosimetry: Where's the Beef?
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 8, p. 1405
- By:
- Publication type:
- Article
Patient-Specific Dosimetry of Pretargeted Radioimmunotherapy Using CC49 Fusion Protein in Patients with Gastrointestinal Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 4, p. 642
- By:
- Publication type:
- Article
Bone Marrow Dosimetry Using Blood-Based Models for Radiolabeled Antibody Therapy: A Multiinstitutional Comparison.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 10, p. 1725
- By:
- Publication type:
- Article
Contribution to Red Marrow Absorbed Dose from Total Body Activity: A Correction to the MIRD Method.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 3, p. 492
- By:
- Publication type:
- Article
How Far Have We Come with Solid (Nonhematologic) Tumor Radioimmunotherapy?
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 12, p. 2011
- By:
- Publication type:
- Article
Breast Milk Excretion of Radiopharmaceuticals: Mechanisms, Findings, and Radiation Dosimetry.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 5, p. 863
- By:
- Publication type:
- Article
Clinical Optimization of Pretargeted Radioimmunotherapy with Antibody- Streptavidin Conjugate and <sup>90</sup>Y-DOTA-Biotin.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 1, p. 131
- By:
- Publication type:
- Article
Marrow Toxicity and Radiation Absorbed Dose Estimates from Rhenium- 186-Labeled Monoclonal Antibody.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 10, p. 1746
- By:
- Publication type:
- Article
Pharmacokinetics and Normal Organ Dosimetry Following Intraperitoneal Rhenium-186-Labeled Monoclonal Antibody.
- Published in:
- Journal of Nuclear Medicine, 1995, v. 36, n. 5, p. 754
- By:
- Publication type:
- Article
Wall Dose Estimates.
- Published in:
- Journal of Nuclear Medicine, 1994, v. 35, n. 1, p. 191
- By:
- Publication type:
- Article
Rhenium-186-Labeled Chimeric Antibody NR-LU-13: Pharmacokinetics, Biodistribution and Immunogenicity Relative to Murine Analog NR-LU-10.
- Published in:
- Journal of Nuclear Medicine, 1993, v. 34, n. 12, p. 2111
- By:
- Publication type:
- Article
Dosimetry of Rhenium-186-Labeled Monoclonal Antibodies: Methods, Prediction from Technetium-99m-Labeled Antibodies and Results of Phase I Trials.
- Published in:
- Journal of Nuclear Medicine, 1993, v. 34, n. 6, p. 908
- By:
- Publication type:
- Article
Clinical Experience with Rhenium-186-Labeled Monoclonal Antibodies for Radioimmunotherapy: Results of Phase I Trials.
- Published in:
- Journal of Nuclear Medicine, 1992, v. 33, n. 6, p. 1099
- By:
- Publication type:
- Article